Lipids in Health and Disease

Table 1 General characteristics of study subjects.

From: Advanced glycation end products (AGEs) in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patients

	DM(N = 207)						DN(N = 174)
	Male(N = 81)			Female(N = 126)			Male(N = 71)			Female(N = 103)
	Mean	±	S.D	Mean	±	S.D	Mean	±	S.D	Mean	±	S.D
Age(yr)	63.5	±	8.7	62.4	±	7.2^y	66.3	±	8.9	64.9	±	6.8
Weight(kg)	69.9	±	9.3***	61.6	±	10.0	70.0	±	9.3***	62.5	±	9.7
BMI(kg/m²)	25.4	±	2.9	25.3	±	3.7	25.3	±	3.2	26.2	±	3.9
AGEs(AU)	1.7	±	1.3	1.9	±	1.3^y	1.9	±	1.5*	2.4	±	1.5
Glucose(mg/dL)	143.0	±	38.5	148.8	±	42.2	152.1	±	54.6	157.2	±	57.4
HbAlc(%)	7.9	±	1.4*	8.3	±	1.4^a	8.4	±	1.7	8.8	±	2.0
CHOL(mg/dL)	177.4	±	32.7***	195.3	±	38.3	175.5	±	44.4***	203.0	±	39.4
TG(mg/dL)	140.6	±	75.5^a	144.4	±	63.1^y	179.7	±	125.0	189.0	±	106.8
HDL-C(mg/dL)	45.9	±	10.1***	56.1	±	13.2	43.2	±	10.2***	53.0	±	13.0
LDL-C(mg/dL)	114.4	±	30.4*	124.6	±	34.7	116.1	±	35.1*	129.8	±	38.2
CHOL/HDL-C	4.0	±	1.1*	3.7	±	1.1^y	4.3	±	1.4	4.1	±	1.2
LDL-C/HDL-C	2.6	±	0.8	2.4	±	0.9	2.8	±	1.0	2.6	±	0.9
TG/HDL-C	3.4	±	2.3^a	2.9	±	1.8^z	4.6	±	3.6	4.0	±	2.7
AI	6.2	±	1.7	6.2	±	1.9^y	6.7	±	1.9	6.9	±	1.8

* p < 0.05, ** p < 0.01, *** p < 0.001 when compared by gender.
^ap < 0.05^bp < 0.01^cp < 0.001 when compared with different statuses in males
^xp < 0.05^yp < 0.01^zp < 0.001 when compared with different statuses in females
BMI: body mass index; AGEs: advanced glycation end products; HbA1c: hemoglobin A1c; CHOL: cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein-cholesterol; LDL-C: low density lipoprotein-cholesterol; AI: atherosclerotic index

Back to article page

ISSN: 1476-511X

Contact us

General enquiries: journalsubmissions@springernature.com